Olopatadine use while Breastfeeding
Drugs containing Olopatadine: Patanol, Pataday, Pazeo, Pataday Once Daily Relief, Patanase, Pataday Twice Daily Relief
Medically reviewed by Drugs.com. Last updated on Feb 13, 2021.
Olopatadine Levels and Effects while Breastfeeding
Summary of Use during Lactation
Because absorption from the eye is limited, olopatadine would not be expected to cause any adverse effects in breastfed infants. To substantially diminish the amount of drug that reaches the breastmilk after using eye drops, place pressure over the tear duct by the corner of the eye for 1 minute or more, then remove the excess solution with an absorbent tissue.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Substance Identification
Substance Name
Olopatadine
CAS Registry Number
113806-05-6
Drug Class
-
Breast Feeding
-
Lactation
-
Anti-Allergic Agents
-
Antihistamines
-
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
